Dr Agarwals Healthcare IPO Review: Apply or Avoid?
Posted by : sachet | Fri Jan 24 2025
Dr Agarwals Healthcare IPO is all set to open on 29th January 2025. Brokers and investors are awaiting the IPO’s tentative listing date, 5th February 2025. It is the book-built of 7,53,04,970 shares worth Rs 3,027.26 crore. It comprised a fresh issue of 754,62,686 shares and an offer for sale of 6,78,42,284 shares.
Dr Agarwals Healthcare IPO
Dr Agarwals Healthcare IPO date is fixed as 29th January 2025 to 31st January 2025. The face value of Dr Agarwals Healthcare Limited shares is Rs 1 per share, and the IPO price band is set between Rs 382 and Rs 402 per share.
Kfin Technologies Limited is the registrar of this IPO and is responsible for managing the allotment process and refund initiation. If you want to get detailed information on this IPO and the company’s fundamentals, download the Dr Agarwals IPO RHP. Also, check the table provided below to learn about Dr Agarwals Healthcare IPO date, price, and issue size.
| IPO Open Date | 29th January 2025 |
| IPO Close Date | 31st January 2025 |
| IPO Allotment Date | 3rd February 2025 |
| Refund Date | 4th February 2025 |
| Face Value | Rs 1 per share |
| Lot Size | 35 Shares |
| Issue Size | 7,53,04,970 shares (worth Rs 3,027.26 crore) |
| Price Band | Rs 382 to Rs 402 per share |
| Issue Type | Book Built IPO |
| Listing At | BSE & NSE |
| Listing Date | 5th February 2025 |
Dr Agarwals Healthcare IPO Details: Check GMP, Price, Issue Size, and More
Dr Agarwals Healthcare IPO will be open to bid for 7,53,04,970 shares worth Rs 3,027.26 crore. Dr Agarwals Healthcare Limited stocks will be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). As per the guidelines of the Securities Exchange Board of India (SEBI), companies are required to reserve a percentage of shares for different categories of investors. Explore the reservation category for this IPO in the table below.
| Investor Category | Reserved Quota (in %) |
| QIB | <50% of net issue |
| NII (sNII+bNII) | >15% of net issue |
| Retail Investors | >35% of net issue |
Note: QIB (Qualified Institutional Buyers), NII (Non-Institutional Investors), sNII (Small Non-Institutional Investors), bNII (Big Non-Institutional Investors).
Dr Agarwals Healthcare IPO GMP Grey Market Premium
Before applying for any IPO, it is essential to check the GMP data. You can check for the Dr Agarwals Healthcare IPO GMP. Consider the table below to learn about the IPO’s live GMP figures, estimated listing price, and gain for 5th January 2025.
| Date | GMP (in Rs) | Estimated Listing Price (in Rs) | Listing Gain (in %) |
| 27th January 2025 | 32 | 434 | 7.96% |
| 26th January 2025 | 32 | 434 | 7.96% |
| 25th January 2025 | 30 | 432 | 7.46% |
| 24th January 2025 | 54 | 456 | 13.43% |
*Data is updated as of 27th January 2025.
As of 27th January 2025, Dr Agarwals Healthcare IPO GMP stands at Rs 32 (7.96% up from the IPO price). It indicates that shares are expected to be listed at Rs 434 on its tentative listing day, 5th February 2025. It should be noted that Dr Agarwals Healthcare IPO GMP Grey Market Premium is subject to be updated on a daily basis. You can check for live GMP status daily in this table.
Dr Agarwals Healthcare IPO Review and Analysis
Dr Agarwals Healthcare Limited has performed extraordinarily over the past few decades. Investors have a positive outlook for Dr Agarwals IPO but also suggested applying for it after thorough research on the IPO review and details. Here is the Dr Agarwals Healthcare IPO review and analysis to help you make informed investment decisions to avoid significant losses in the share market.
- Company’s Financial Health
Assessment of the financial performance of a company is vital to applying for its IPO. It suggests the company’s efficiency in integrating innovative measures and expanding business in the competitive landscape. Investors can consider financial parameters like revenue, PAT, net assets, etc.
In FY2023-24, the revenue of Dr. Agarwal’s Healthcare Limited was increased by 33.44% from Rs 1,031.49 crore to Rs 1,376.45 crore. In contrast, net worth, which stood at Rs 627.83 crore on 31st March 2023, rose by 113.06% to reach Rs 1,337.68 crore on 31st March 2024. On the other hand, profit after tax (PAT) has shown a decline of 7.92% and reached Rs 95.05 crore during the same period.
Impeccable revenue and net worth growth indicate that Dr Agarwals Healthcare IPO will get higher engagement and attention from investors and may also deliver higher listing gains. However, the above figures and viewpoints are taken from authentic sources, and it is suggested that investors should consider their own research before applying for an IPO.
- Technical Analysis
Technical analysis of a stock could give a clear picture of its potential to grow in the coming time. You can consider different parameters in your technical research. Have a look at the table below, including the technicals of Dr Agarwals Healthcare IPO analysis.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 130.44 |
| PB Ratio (Price-to-Book) | 7.96 |
| EPS (Earnings Per Share) | 3.08 |
| ROE (Return on Equity) | 9.33% |
| Debt-to-Equity Ratio | 0.70 |
| RoCE | 14.61% |
| PAT Margin (Profit After Tax) | 6.90 |
| Market Capitalisation | Rs 12,698.37 crore |
*Data is updated as of 24th January 2025.
- Inventory Turnover Ratio
As per the research conducted, it has been found that the inventory turnover ratio of Dr Agarwals Healthcare Limited was slightly increased. It indicates that the company is focusing on efficient inventory management, which would result in rapid growth in sales. A higher inventory turnover ratio of the company will indirectly increase its future sales.
- Dr Agarwals Healthcare IPO Listing
Dr Agarwals Healthcare IPO listing date is prescribed as 5th February 2025. As of now (24th January 2025), the share is currently trading at 21.14% (Rs 85 per share), up from its IPO price in the grey market. Thus, the estimated listing price, as per the current updates, could be Rs 487 (85+402).
As there is time remaining for the IPO opening, these figures could be changed according to the market sentiments and GMP fluctuations. Check for the live GMP or updated listing price before applying for this IPO.
- Dr Agarwals Healthcare Limited Peer Comparison
| Company Name | Revenue (in cr.) | PE Ratio | Face Value (in Rs) | EPS (in Rs) | RoNW (in %) | NAV (in Rs) |
| Dr Agarwals Healthcare Limited | 1,376.45 | 130.44 | 1 | 3.08 | 6.21% | 50.53 |
| Jupiter Life Line Hospitals Limited | 940.26 | 55.08 | 10 | 28.22 | 15.77% | 191.93 |
| Max Healthcare Institute Limited | 1,420.00 | 97.03 | 10 | 10.89 | 8.49% | 90.51 |
| Global Health Limited | 825.53 | 75.60 | 2 | 14.16 | 12.14% | 113.50 |
| Fortis Healthcare Limited | 1,790.42 | 73.16 | 10 | 8.69 | 1.37% | 103.94 |
| Apollo Hospitals Enterprise Limited | 4,940.70 | 84.13 | 5 | 82.28 | 15.67% | 521.15 |
| Krishna Institute of Medical Sciences Limited | 633.80 | 74.67 | 2 | 8.28 | 23.30% | 50.03 |
| Rainbow Children’s Medicare Limited | 341.10 | 64.50 | 10 | 22.80 | 17.23% | 132.29 |
| Healthcare Global Limited | 1,087.90 | 126.00 | 10 | 4.09 | 4.21% | 61.82 |
| Narayana Hrudayalaya Limited | 1,280.00 | 34.82 | 10 | 38.11 | 27.29% | 156.86 |
| Aster DM Healthcare Limited | 973.59 | 4.62 | 10 | 108.05 | 3.58% | 60.41 |
*Data is updated as of 24th January 2025.
Note: The above-mentioned figures are taken from authentic sources but represent the data from the pre-issue period. PE ratio and EPS are subject to change post-issue. Explore the table below to have precise information about both of these indicators on Ds Agarwals Healthcare Limited.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 130.44 | 160.48 |
| EPS | 3.08 | 2.51 |
*Data is updated as of 24th January 2025.
The PE ratio of Dr Agarwals Healthcare Limited stands at 130.44, and EPS (Earnings Per Share) is 3.08.
About Dr Agarwals Healthcare Limited
Dr Agarwals Healthcare Limited was incorporated in 2010 and offers different eye care services like refractive surgeries, diagnoses, non-surgical treatments, opticals, contact lenses, pharmaceutical items, and consultations. As per the updates on 30th September 2024, the company had 737 doctors to operate across diverse regions. Till then, the company has served around 21,30,000 patients with 2,20,523 surgeries.
Dr Agarwal Healthcare Limited has shown impressive growth over the past few decades and expanded its business across 117 metro and non-metro cities. With a proven track record of growth and integration, this company has gained high recognition and attention in the market.
Dr Agarwals Healthcare Limited’s Financial Analysis
Assess the company’s financial performance before applying for Dr Agarwals Healthcare IPO. This assessment would help you know about the robust strength of a business firm against its competitors in the market. Have a look at the table below to learn about the financials of the company.
| Year Ended | 30th Sept 2024 (in cr.) | 31st Mar 2024 (in cr.) | 31st Mar 2023 (in cr.) | 31st Mar 2022 (in cr.) |
| Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 |
| Borrowings | 373.68 | 387.79 | 356.18 | 290.18 |
| Revenue | 837.94 | 1,376.45 | 1,031.49 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
| Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
*Data is updated as of 24th January 2025.
Explanation
Dr Agarwals Healthcare Limited has shown a robust growth of 33.4% in its revenue and 113.06% in its net worth during FY23-24. On the other side, there was a slight decline of 7.92% in the net profit after tax of the company.
Dr Agarwals Healthcare IPO Bidding Requirements
Know how much or how many are available for different categories of investors to place a bid on Dr Agarwals Healthcare IPO. Explore the table to learn about minimum and maximum criteria.
| Investor Category | Lots | Shares | Amount (in Rs) |
| Retail (Minimum) | 1 | 35 | 14,070 |
| Retail (Maximum) | 14 | 490 | 1,96,980 |
| sNI (Minimum) | 15 | 525 | 2,11,050 |
| sNII (Maximum) | 71 | 2,485 | 9,98,970 |
| bNII (Minimum) | 72 | 2,520 | 10,13,040 |
Aim of Dr Agarwals Healthcare IPO
The primary aim of Dr Agarwals Healthcare IPO is to raise Rs 3,027.26 crore. But, the company is going to utilise these funds in different ways. Explore some of the secondary objectives behind this IPO to have an idea about the company’s long-term potential against other pharma stocks.
- Repayment of Borrowings: Dr Agarwal Healthcare Limited is looking to repay its debt from the funds likely to be received through this book-built issue. It will help them save the interest payment and may also influence the financial stability of the business.
- General Corporate Purposes: The remaining funds will be utilised to meet the general corporate purposes of Dr Agarwal Healthcare Limited. The company also aims to utilise them for unidentified inorganic acquisitions.
Challenges for Dr Agarwals Healthcare IPO
This is all about Dr Agarwals Healthcare IPO review and analysis. Now is the right time to explore some of the challenges an individual might face when applying for this IPO. Explore them in the below section.
- Economic Slowdowns
Though Dr Agarwals Healthcare Limited has efficiently managed its inventory, the economic downturns might impact its sales figures in the coming decades. These downturns include recession, inflation, low disposable income, etc.
- Technological Integration
We’re living in an evolving technological era. And it is essential for businesses to integrate new technologies into their organisational structure, specifically in the healthcare sector. However, it could be challenging for Dr Agarwal Healthcare Limited to integrate new technologies prior to their competitors. It might create a challenging situation for investors looking to hold this share for a long duration.
- Aggressive Competition
The healthcare sector in India is highly competitive. The availability of giant competitors might create hurdles for a business to sustain its financial position. Moreover, aggressive competition in the healthcare industry may also impact the expansion of the business into vast market areas.
- Decline in Revenue
The decline in revenue in FY23-24 might be a challenge for Dr Agarwal Healthcare IPO listing. It can impact investors’ behaviour or decisions for making a bid for the IPO. This decline might impact IPO grey market premium in the short term.
Should I Invest in Dr Agarwals Healthcare IPO
Experts have a positive outlook for Dr Agarwals IPO. Besides this, they have suggested investors conduct their research on its pros and cons to know whether they should apply for Dr Agarwals Healthcare IPO or not. A few people are still confused about what pros and cons are to be considered. Relax until you’re reading Univest. We’re here with key benefits and risks for investing in this IPO. Scroll to learn more.
Pros of Dr Agarwals Healthcare IPO
- Consistent growth in net worth and profit after tax (PAT).
- Diversified business structure across different regions in India.
- The company aims to reduce debt from IPO receipts.
- Significant increase in inventory turnover ratio.
- Higher chance for dividend yield because of effective cash flow position. d
Cons of Dr Agarwals Healthcare IPO
- Slight decline in revenue during FY23-24.
- Availability of giant players in the healthcare sector.
It should be your own choice whether to apply for this IPO or not. You can consider Dr Agarwal Healthcare IPO review and analysis above in your research. It is recommended to check the company’s financials and fundamentals to avoid significant losses in the share market.
How to Apply for Dr Agarwals Healthcare IPO
It is easy to apply for Dr Agarwals Healthcare IPO online. You just need to follow some steps mentioned below.
- Step 1: Conduct research on Dr Agarwals Healthcare IPO details, GMP, Price, and more.
- Step 2: Get registered with a broker and open a demat account. You can open a demat account on Univest to get the latest insights on IPOs and verdicts.
- Step 3: Make an IPO bid for a minimum of 35 shares worth Rs 14,070.
- Step 4: Once you’re done with this bid, you will receive a mandate request. Approve the request and wait for the allotment to be finalised.
Check Dr Agarwals Healthcare IPO Allotment Status Online
Dr Agarwals Healthcare IPO allotment status is to be finalised on 3rd February 2025. Kfin Technologies Limited is the registrar of this IPO and awaits to finalise the allotment process. You can check the IPO allotment through two different methods. These include the BSE and Registrar Portal.
Check on BSE
- Visit the BSE official website.
- Select Equity as the issue type.
- Choose Dr Agarwal Healthcare IPO.
- Select whether to proceed with the PAN number or application number.
- Submit your information to check the allotment status online.
Check on Registrar
- Visit the registrar portal.
- Select IPO as Dr Agarwal Healthcare Limited.
- Fill in the required details.
- Click on the submit button to know your allotment status.
Final Thoughts
Dr Agarwals Healthcare IPO is the book-built issue of 7,53,04,970 shares worth Rs 3,027.26 crore. The IPO is expected to get mass attention and engagement from investors and will be listed on BSE and NSE on its tentative listing date, 5th February 2025. Though investors have a positive outlook for this IPO, it never guarantees multibaggers listing gains. Thus, one should conduct own research on its challenges, pros, cons, Grey Market Premium, price, etc., before applying for it. This research would be a safeguard against significant losses in the share market. So, what are you waiting for, explore the Dr Agarwals Healthcare IPO review and analysis to make an informed investment decision.
Download the Univest Android app or Univest iOS app to get detailed insights into Dr Agarwals Healthcare’s IPO date, price, GMP, and subscription.
Explore Previous IPOs
H.M. Electro Mech IPO Review: Apply or Avoid?
Denta Water and Infra IPO 2025 Live Updates and Reviews
Stallion India IPO 2025: Check Live GMP Details and Investment Insights
Laxmi Dental IPO Today: Know Day 2 GMP, Subscription Status, and Other Key Details
Indo Farm Equipment Share Listing: What Investors Need to Know?
Transrail Lighting IPO: Fundamental Analysis
FAQs on Dr Agarwals Healthcare IPO
1. Is Dr Agarwals Healthcare IPO good?
Ans. Dr Agarwals IPO is top on the list of investors’ favourable investment opportunities. The company aims to repay its debt through IPO receipts and has shown consistent financial growth over the past few decades. This growth and high market cap of Dr Agarwals Healthcare Limited reflects its long-term potential.
2. How is Dr Agarwals Healthcare IPO?
Ans. Dr Agarwal Healthcare IPO GMP Grey Market Premium stands at Rs 85 (21.14% up from the IPO price) on 24th January 2025. The GMP indicates that the share is expected to list at Rs 487 on 5th February 2025. However, the IPO price band is set between Rs 382 and Rs 402 per share, and each share’s face value is Rs 1.
3. What is the price of Dr Agarwals Healthcare IPO?
Ans. Dr Agarwal Healthcare IPO price band has been set between Rs 382 and Rs 402 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 35 shares worth Rs 14,070. Moreover, sNIIs are required to bid for a minimum of 15 lots (525 shares) worth Rs 2,11,050.
4. Who is the registrar of Dr Agarwals Healthcare IPO?
Ans. Kfin Technologies Limited is the registrar of this IPO, awaiting to manage the IPO allotment and refund initiation process. For any query on Dr Agarwals Healthcare IPO allotment and refund, reach out to reachus@kfintech.com or 04067162222 / 04079611000.
5. What is the issue size of Dr Agarwals IPO?
Ans. Dr Agarwal Healthcare IPO is the book-built issue of 7,53,04,970 shares worth Rs 3,027.26 crore. It comprised a fresh issue of 754,62,686 shares (worth Rs 300 crore) and an offer for sale of 6,78,42,284 shares (worth Rs 2,727.26 crore).
Disclaimer: The above information is accumulated from authentic sources and is just for informational purposes. To have detailed information about Dr Agarwal Healthcare IPO, download the Dr Agarwal Healthcare IPO RHP and Dr Agarwal Healthcare IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
